10-K Decoder · All companies

X4 Pharmaceuticals, Inc.

XFOR · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$35.1M$2.56M+1,271%
Operating income−$86.9M−$36.4M−139%
Net income−$79.2M−$37.5M−111%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$2.90M$1.80M+61.1%
Operating income−$20.0M−$27.5M+27.3%
Net income−$20.2M−$29.8M+32.2%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was X4 Pharmaceuticals's revenue in FY2025?
$35.1M in FY2025 (Fiscal year ended Dec 31, 2025), +1,271% vs $2.56M a year earlier, per its 10-K filed Mar 2026.
Was X4 Pharmaceuticals profitable in FY2025?
No: net income was −$79.2M and operating income −$86.9M in FY2025.
What was X4 Pharmaceuticals's revenue in Q3 2026?
$2.90M (+61.1% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.